Gujarat Gas Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 15, 2025, 8:32 pm

Quick Insight

Gujarat Gas Ltd, priced at ₹433 with a MarketCap of ₹29,814 Cr, showcases robust financial metrics within India's Gas Transmission/Marketing sector. With a P/E ratio of 26.0 and a healthy ROCE of 19.5%, the company demonstrates efficient capital utilization. Furthermore, its comfortable Interest Coverage Ratio (ICR) of 67.64x indicates a strong ability to service debt. Gujarat Gas's high Return on Equity (ROE) of 14.2% and a relatively low Price-to-Book Value (P/BV) ratio of 4.85x suggest solid profitability and reasonable valuation compared to industry peers. The company's operational performance, with an Operating Profit Margin (OPM) of 13%, signifies effective cost management strategies.

Despite these strengths, Gujarat Gas faces risks such as its moderate Current Ratio of 1.23x, indicating a potential liquidity challenge. Additionally, the company’s high dependence on promoters (60.89%) could raise concerns about corporate governance and minority shareholder interests. Looking ahead, Gujarat Gas's growth prospects appear promising if it can capitalize on the increasing demand for natural gas in India's energy mix. However, regulatory changes impacting gas pricing or distribution could pose challenges to its profitability and expansion plans, requiring proactive risk management strategies to navigate potential headwinds.

In conclusion, Gujarat Gas Ltd presents a compelling investment opportunity given its solid financial performance and growth potential within the dynamic Indian energy sector. Investors should closely monitor regulatory developments and the company's efforts to diversify its shareholder base to mitigate risks and capitalize on emerging opportunities in the evolving gas market landscape.

Competitors of Gujarat Gas Ltd

All Competitor Stocks of Gujarat Gas Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:00 am

Below is a detailed analysis of the quarterly data for Gujarat Gas Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,871.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,102.00 Cr. (Mar 2025) to 3,871.00 Cr., marking a decrease of 231.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,351.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,652.00 Cr. (Mar 2025) to 3,351.00 Cr., marking a decrease of 301.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 520.00 Cr.. The value appears strong and on an upward trend. It has increased from 450.00 Cr. (Mar 2025) to 520.00 Cr., marking an increase of 70.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 13.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 60.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 15.00 Cr..
• For Interest, as of Jun 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 131.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 129.00 Cr. (Mar 2025) to 131.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 441.00 Cr.. The value appears strong and on an upward trend. It has increased from 389.00 Cr. (Mar 2025) to 441.00 Cr., marking an increase of 52.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 328.00 Cr.. The value appears strong and on an upward trend. It has increased from 288.00 Cr. (Mar 2025) to 328.00 Cr., marking an increase of 40.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.76. The value appears strong and on an upward trend. It has increased from 4.18 (Mar 2025) to 4.76, marking an increase of 0.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 15, 2025, 5:01 am

Growth

Last Updated: September 5, 2025, 5:35 am

Balance Sheet

Last Updated: June 16, 2025, 12:03 pm

Below is a detailed analysis of the balance sheet data for Gujarat Gas Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 138.00 Cr..
• For Reserves, as of Mar 2025, the value is 8,352.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,585.00 Cr. (Mar 2024) to 8,352.00 Cr., marking an increase of 767.00 Cr..
• For Borrowings, as of Mar 2025, the value is 150.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 150.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,011.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,819.00 Cr. (Mar 2024) to 4,011.00 Cr., marking an increase of 192.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 12,651.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,692.00 Cr. (Mar 2024) to 12,651.00 Cr., marking an increase of 959.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 8,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,763.00 Cr. (Mar 2024) to 8,223.00 Cr., marking an increase of 460.00 Cr..
• For CWIP, as of Mar 2025, the value is 824.00 Cr.. The value appears to be declining and may need further review. It has decreased from 918.00 Cr. (Mar 2024) to 824.00 Cr., marking a decrease of 94.00 Cr..
• For Investments, as of Mar 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 168.00 Cr. (Mar 2024) to 172.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,433.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,842.00 Cr. (Mar 2024) to 3,433.00 Cr., marking an increase of 591.00 Cr..
• For Total Assets, as of Mar 2025, the value is 12,651.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,692.00 Cr. (Mar 2024) to 12,651.00 Cr., marking an increase of 959.00 Cr..

Notably, the Reserves (8,352.00 Cr.) exceed the Borrowings (150.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gujarat Gas Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 16.61. This value is within the healthy range. It has decreased from 22.20 (Mar 23) to 16.61, marking a decrease of 5.59.
• For Diluted EPS (Rs.), as of Mar 24, the value is 16.61. This value is within the healthy range. It has decreased from 22.20 (Mar 23) to 16.61, marking a decrease of 5.59.
• For Cash EPS (Rs.), as of Mar 24, the value is 23.47. This value is within the healthy range. It has decreased from 28.38 (Mar 23) to 23.47, marking a decrease of 4.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 112.18. It has increased from 102.09 (Mar 23) to 112.18, marking an increase of 10.09.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 112.18. It has increased from 102.09 (Mar 23) to 112.18, marking an increase of 10.09.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 227.92. It has decreased from 243.45 (Mar 23) to 227.92, marking a decrease of 15.53.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 28.80. This value is within the healthy range. It has decreased from 36.22 (Mar 23) to 28.80, marking a decrease of 7.42.
• For PBIT / Share (Rs.), as of Mar 24, the value is 21.91. This value is within the healthy range. It has decreased from 30.00 (Mar 23) to 21.91, marking a decrease of 8.09.
• For PBT / Share (Rs.), as of Mar 24, the value is 22.29. This value is within the healthy range. It has decreased from 29.41 (Mar 23) to 22.29, marking a decrease of 7.12.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 16.58. This value is within the healthy range. It has decreased from 22.16 (Mar 23) to 16.58, marking a decrease of 5.58.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 16.61. This value is within the healthy range. It has decreased from 22.20 (Mar 23) to 16.61, marking a decrease of 5.59.
• For PBDIT Margin (%), as of Mar 24, the value is 12.63. This value is within the healthy range. It has decreased from 14.87 (Mar 23) to 12.63, marking a decrease of 2.24.
• For PBIT Margin (%), as of Mar 24, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 12.32 (Mar 23) to 9.61, marking a decrease of 2.71.
• For PBT Margin (%), as of Mar 24, the value is 9.78. This value is below the healthy minimum of 10. It has decreased from 12.08 (Mar 23) to 9.78, marking a decrease of 2.30.
• For Net Profit Margin (%), as of Mar 24, the value is 7.27. This value is within the healthy range. It has decreased from 9.10 (Mar 23) to 7.27, marking a decrease of 1.83.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.28. This value is below the healthy minimum of 8. It has decreased from 9.11 (Mar 23) to 7.28, marking a decrease of 1.83.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.81. This value is below the healthy minimum of 15. It has decreased from 21.74 (Mar 23) to 14.81, marking a decrease of 6.93.
• For Return on Capital Employeed (%), as of Mar 24, the value is 16.99. This value is within the healthy range. It has decreased from 25.41 (Mar 23) to 16.99, marking a decrease of 8.42.
• For Return On Assets (%), as of Mar 24, the value is 9.78. This value is within the healthy range. It has decreased from 13.98 (Mar 23) to 9.78, marking a decrease of 4.20.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.39. It has decreased from 1.63 (Mar 23) to 1.39, marking a decrease of 0.24.
• For Current Ratio (X), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 1.5. It has increased from 0.70 (Mar 23) to 0.79, marking an increase of 0.09.
• For Quick Ratio (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.68 (Mar 23) to 0.77, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 209.52. This value exceeds the healthy maximum of 8. It has decreased from 231.76 (Mar 23) to 209.52, marking a decrease of 22.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 40.02. This value is within the healthy range. It has increased from 9.00 (Mar 23) to 40.02, marking an increase of 31.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 28.29. This value is within the healthy range. It has increased from 7.03 (Mar 23) to 28.29, marking an increase of 21.26.
• For Earning Retention Ratio (%), as of Mar 24, the value is 59.98. This value is within the healthy range. It has decreased from 91.00 (Mar 23) to 59.98, marking a decrease of 31.02.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 71.71. This value exceeds the healthy maximum of 70. It has decreased from 92.97 (Mar 23) to 71.71, marking a decrease of 21.26.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 67.64. This value is within the healthy range. It has increased from 61.79 (Mar 23) to 67.64, marking an increase of 5.85.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 38.03. This value is within the healthy range. It has decreased from 38.81 (Mar 23) to 38.03, marking a decrease of 0.78.
• For Enterprise Value (Cr.), as of Mar 24, the value is 36,540.05. It has increased from 30,964.77 (Mar 23) to 36,540.05, marking an increase of 5,575.28.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.33. This value is within the healthy range. It has increased from 1.85 (Mar 23) to 2.33, marking an increase of 0.48.
• For EV / EBITDA (X), as of Mar 24, the value is 18.43. This value exceeds the healthy maximum of 15. It has increased from 12.42 (Mar 23) to 18.43, marking an increase of 6.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.39. This value is within the healthy range. It has increased from 1.89 (Mar 23) to 2.39, marking an increase of 0.50.
• For Retention Ratios (%), as of Mar 24, the value is 59.97. This value is within the healthy range. It has decreased from 90.99 (Mar 23) to 59.97, marking a decrease of 31.02.
• For Price / BV (X), as of Mar 24, the value is 4.85. This value exceeds the healthy maximum of 3. It has increased from 4.50 (Mar 23) to 4.85, marking an increase of 0.35.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.39. This value is within the healthy range. It has increased from 1.89 (Mar 23) to 2.39, marking an increase of 0.50.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness